4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-042725
Chief Executive Officer sold 26,172 shares at an average $8.77 ($229,624)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2025-03-18 | Sale 10b5-1 | −25,772 | $8.77 | $226,023 | 226,140 | D: show line 1 in the form |
| Tak Paul Peter Chief Executive Officer | 2025-03-19 | Sale 10b5-1 | −400 | $9.00 | $3,601 | 225,740 | D: show line 2 in the form |
| Open-market sales · 26,172 sh · avg $8.77 · $229,624 | |||||||
Loading xslF345X05/ownership.xml…